SCHEMBL20141122

SCHEMBL20141122

N#Cc1ccccc1N1CC(NC(=O)O)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 2/20 0.48
DRD4 P21917 6/20 0.47
DRD2 P14416 4/20 0.47
GRM5 P41594 1/20 0.44
DRD3 P35462 3/20 0.43
DPP4 P27487 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
HTR2A P28223 1/20 0.41
THPO P40225 1/20 0.41
HIF1A Q16665 1/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31042527 0.85 DRD4 (0.51) DRD4DRD2GRM5DRD3ALDH1A1
SCHEMBL20133542 0.80 CTSK (0.48) GRM1DRD4DRD2GRM5DRD3
SCHEMBL17188024 0.78 NOTUM (0.45)
SCHEMBL25267978 0.78 NOTUM (0.45)
SCHEMBL2558382 0.77 DRD2 (0.37) DRD4DRD2ALDH1A1CHRM4LMNA
SCHEMBL30164064 0.76 FFAR4 (0.39) DRD4
SCHEMBL20140686 0.76 GRM1 (0.64) GRM1DRD4DRD2GRM5DPP4
SCHEMBL27488325 0.75 GRM1 (0.49) GRM1DRD4DRD2GRM5DRD3
SCHEMBL30619380 0.75 GRM1 (0.49) GRM1DRD4DRD2GRM5DRD3
SCHEMBL19641755 0.75 CHRM2 (0.48) DRD2DRD3ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed